Search Results - "Breckenridge, Alasdair M"

Refine Results
  1. 1

    Mini-Sentinel and Regulatory Science — Big Data Rendered Fit and Functional by Psaty, Bruce M, Breckenridge, Alasdair M

    Published in The New England journal of medicine (05-06-2014)
    “…Under the leadership of the FDA and study investigators, the Mini-Sentinel project has not only transformed big medical data into a national research resource…”
    Get full text
    Journal Article
  2. 2

    Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients by Pirmohamed, Munir, James, Sally, Meakin, Shaun, Green, Chris, Scott, Andrew K, Walley, Thomas J, Farrar, Keith, Park, B Kevin, Breckenridge, Alasdair M

    Published in BMJ (03-07-2004)
    “…Abstract Objective To ascertain the current burden of adverse drug reactions (ADRs) through a prospective analysis of all admissions to hospital. Design…”
    Get full text
    Journal Article
  3. 3

    Report on the current status of the use of real‐world data (RWD) and real‐world evidence (RWE) in drug development and regulation by Breckenridge, Alasdair M., Breckenridge, Ross A., Peck, Carl C.

    Published in British journal of clinical pharmacology (01-09-2019)
    “…Radically expanding use of real‐world data (RWD) and real‐world evidence (RWE) holds the potential to substantially impact drug development, pharmaceutical…”
    Get full text
    Journal Article
  4. 4

    Observations on Three Endpoint Properties and Their Relationship to Regulatory Outcomes of European Oncology Marketing Applications by Liberti, Lawrence, Stolk, Pieter, McAuslane, James Neil, Schellens, Jan, Breckenridge, Alasdair M., Leufkens, Hubert

    Published in The oncologist (Dayton, Ohio) (01-06-2015)
    “…Background. Guidance and exploratory evidence indicate that the type of endpoints and the magnitude of their outcome can define a therapy's clinical activity;…”
    Get full text
    Journal Article
  5. 5

    Reporting of adverse drug reactions by nurses by Morrison-Griffiths, Sally, Walley, Thomas J, Park, B Kevin, Breckenridge, Alasdair M, Pirmohamed, Munir

    Published in The Lancet (British edition) (19-04-2003)
    “…Schemes for spontaneous reporting of adverse drug reactions are important to post-marketing safety surveillance worldwide. In the UK, doctors, dentists,…”
    Get full text
    Journal Article
  6. 6

    The UK's NHS and pharma: need for more clinical pharmacologists by Aronson, Jeffrey K, Barnett, David B, Breckenridge, Alasdair M, Ferner, Robin E, Jackson, Peter, Maxwell, Simon R, McInnes, Gordon T, Rawlins, Michael D, Ritter, James M, Routledge, Philip, Walley, Tom J, Webb, David J, Williams, David, Woods, Kent L

    Published in The Lancet (British edition) (11-04-2009)
    “…The Wellcome Trust, recognising that clinical pharmacologists can contribute to research as well as teaching, has initiated interdisciplinary training…”
    Get full text
    Journal Article
  7. 7

    Adverse drug reactions by Pirmohamed, Munir, Breckenridge, Alasdair M, Kitteringham, Neil R, Park, B Kevin

    Published in BMJ (25-04-1998)
    “…A problem with spontaneous reporting is that less than 10% of all serious and 2-4% of non-serious adverse reactions are reported. 2 38 All doctors need to be…”
    Get full text
    Journal Article
  8. 8

    An investigation of the formation of cytotoxic, protein-reactive and stable metabolites from carbamazepine in vitro by Pirmohamed, M, Kitteringham, N R, Guenthner, T M, Breckenridge, A M, Park, B K

    Published in Biochemical pharmacology (15-04-1992)
    “…The formation of chemically reactive metabolites from carbamazepine (CBZ) in the presence of mouse and human liver microsomes has been investigated using…”
    Get more information
    Journal Article
  9. 9

    Clinical pharmacokinetics of anthelmintic drugs by EDWARDS, G, BRECKENRIDGE, A. M

    Published in Clinical pharmacokinetics (01-08-1988)
    “…A rational strategy for chemotherapy demands that dosage schedules be based on an adequate knowledge of clinical and biochemical pharmacology. Many…”
    Get full text
    Journal Article
  10. 10

    Effect of malaria infection and endotoxin-induced fever on phenacetin O-deethylation by rat liver microsomes by Kokwaro, G O, Glazier, A P, Ward, S A, Breckenridge, A M, Edwards, G

    Published in Biochemical pharmacology (24-03-1993)
    “…We have investigated the effect of malaria infection with the rodent parasite Plasmodium berghei and fever induced by Escherichia coli endotoxin on the…”
    Get more information
    Journal Article
  11. 11
  12. 12

    Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients by MERRY, C, BARRY, M. G, MULCAHY, F, RYAN, M, HEAVEY, J, TJIA, J. F, GIBBONS, S. E, BRECKENRIDGE, A. M, BACK, D. J

    Published in AIDS (London) (15-03-1997)
    “…The most important hepatic enzyme involved in the metabolism of protease inhibitors is cytochrome P450 3A4 (CYP3A4). Ritonavir (RIT) is a potent inhibitor of…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Interaction between diflunisal and warfarin by Serlin, M J, Mossman, S, Sibeon, R G, Tempero, K F, Breckenridge, A M

    Published in Clinical pharmacology and therapeutics (01-10-1980)
    “…The effect of diflunisal on steady-state warfarin dynamics and kinetics was studied in five healthy men taking daily subtherapeutic doses of warfarin…”
    Get more information
    Journal Article
  15. 15

    Diethylcarbamazine disposition in patients with onchocerciasis by Edwards, G, Awadzi, K, Breckenridge, A M, Gilles, H M, Orme, M L, Ward, S A

    Published in Clinical pharmacology and therapeutics (01-10-1981)
    “…Diethylcarbamazine (DEC), 0.5 mg/kg, was taken orally by six patients being treated for onchocerciasis. Blood samples were taken at timed intervals for 48 hr…”
    Get more information
    Journal Article
  16. 16
  17. 17

    The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites by Barry, M G, Khoo, S H, Veal, G J, Hoggard, P G, Gibbons, S E, Wilkins, E G, Williams, O, Breckenridge, A M, Back, D J

    Published in AIDS (London) (01-10-1996)
    “…Zidovudine (ZDV) requires intracellular phosphorylation to ZDV triphosphate (ZDV-TP) prior to the inhibition of HIV replication. The effect of ZDV dose on the…”
    Get more information
    Journal Article
  18. 18

    The pharmacokinetics of combination therapy with nelfinavir plus nevirapine by MERRY, C, BARRY, M. G, MULCAHY, F, RYAN, M, TJIA, J. F, HALIFAX, K. L, BRECKENRIDGE, A. M, BACK, D. J

    Published in AIDS (London) (09-07-1998)
    “…To investigate the pharmacokinetics of nelfinavir (NFV) administered alone and in combination with nevirapine (NVP) to HIV-positive patients. Seven patients…”
    Get full text
    Journal Article
  19. 19

    Intracellular glutathione in the peripheral blood cells of HIV-infected patients: failure to show a deficiency by Pirmohamed, M, Williams, D, Tingle, M D, Barry, M, Khoo, S H, O'Mahony, C, Wilkins, E G, Breckenridge, A M, Park, B K

    Published in AIDS (London) (01-05-1996)
    “…To determine whether HIV-infected patients have a deficiency of intracellular glutathione (GSH) in peripheral blood mononuclear cells (PBMC) and erythrocytes…”
    Get more information
    Journal Article
  20. 20

    Adverse drug reactions by PIRMOHAMED, M, BRECKENRIDGE, A. M, KITTERINGHAM, N. R, PARK, B. K

    “…Pirmohamed et al discuss the current status of adverse drug reactions, briefly describing the complexity of the more bizarre reactions and outlining a strategy…”
    Get full text
    Journal Article